BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8039243)

  • 1. Long-term inositol phosphate release, but not tyrosine kinase activity, correlates with IL-2 secretion and NF-AT induction in anti-CD3-activated peripheral human T lymphocytes.
    Bryan RG; Li Y; Totten RK; Van M; Tan TH; Rich RR
    Cell Immunol; 1994 Aug; 157(1):158-69. PubMed ID: 8039243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-10 inhibits nuclear factor-kappa B/Rel nuclear activity in CD3-stimulated human peripheral T lymphocytes.
    Romano MF; Lamberti A; Petrella A; Bisogni R; Tassone PF; Formisano S; Venuta S; Turco MC
    J Immunol; 1996 Mar; 156(6):2119-23. PubMed ID: 8690900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of nuclear factor-kappa B and activator protein-1 activities after stimulation of T cells via glycosylphosphatidylinositol-anchored Ly-6A/E.
    Ivanov V; Fleming TJ; Malek TR
    J Immunol; 1994 Sep; 153(6):2394-406. PubMed ID: 7915738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporin A inhibits the early phase of NF-kappaB/RelA activation induced by CD28 costimulatory signaling to reduce the IL-2 expression in human peripheral T cells.
    Nishiyama S; Manabe N; Kubota Y; Ohnishi H; Kitanaka A; Tokuda M; Taminato T; Ishida T; Takahara J; Tanaka T
    Int Immunopharmacol; 2005 Apr; 5(4):699-710. PubMed ID: 15710339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha 4 beta 1 (CD49d/CD29) integrin costimulation of human T cells enhances transcription factor and cytokine induction in the absence of altered sensitivity to anti-CD3 stimulation.
    Udagawa T; Woodside DG; McIntyre BW
    J Immunol; 1996 Sep; 157(5):1965-72. PubMed ID: 8757316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of NF-kappa B nuclear activity in peripheral blood mononuclear cells: role of CD28 antigen.
    Romano MF; Bisogni R; Lamberti A; Turco MC; Petrella A; Tassone P; Van Lier R; Formisano S; Venuta S
    Cell Immunol; 1994 Jul; 156(2):371-7. PubMed ID: 8025954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of primary human T-lymphocytes through CD2 plus CD28 adhesion molecules induces long-term nuclear expression of NF-kappa B.
    Costello R; Lipcey C; Algarté M; Cerdan C; Baeuerle PA; Olive D; Imbert J
    Cell Growth Differ; 1993 Apr; 4(4):329-39. PubMed ID: 8098618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related decreases in IL-2 production by human T cells are associated with impaired activation of nuclear transcriptional factors AP-1 and NF-AT.
    Whisler RL; Beiqing L; Chen M
    Cell Immunol; 1996 May; 169(2):185-95. PubMed ID: 8620546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of HIV gp120 and anti-CD4 antibodies with the CD4 molecule on human CD4+ T cells inhibits the binding activity of NF-AT, NF-kappa B and AP-1, three nuclear factors regulating interleukin-2 gene enhancer activity.
    Jabado N; Le Deist F; Fisher A; Hivroz C
    Eur J Immunol; 1994 Nov; 24(11):2646-52. PubMed ID: 7957556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of NF-kappa B1 (p50/p105) gene expression in activation of human blood T-lymphocytes via CD2 and CD28 adhesion molecules.
    Costello R; Cerdan C; Lipcey C; Algarté M; Martin Y; Baeuerle PA; Olive D; Imbert J
    Cell Growth Differ; 1993 Nov; 4(11):947-54. PubMed ID: 7905283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal regulation of the IL-2 promoter in lpr CD4-CD8- T lymphocytes results in constitutive expression of a novel nuclear factor of activated T cells-binding factor.
    Clements JL; Cooper SM; Budd RC
    J Immunol; 1995 Jun; 154(12):6372-81. PubMed ID: 7759875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Chinese herbal remedy, T2, inhibits mitogen-induced cytokine gene transcription by T cells, but not initial signal transduction.
    Tao X; Davis LS; Hashimoto K; Lipsky PE
    J Pharmacol Exp Ther; 1996 Jan; 276(1):316-25. PubMed ID: 8558449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biphasic control of nuclear factor-kappa B activation by the T cell receptor complex: role of tumor necrosis factor alpha.
    Pimentel-Muiños FX; Mazana J; Fresno M
    Eur J Immunol; 1995 Jan; 25(1):179-86. PubMed ID: 7843230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiologic activation of T cells via the T cell receptor induces NF-kappa B.
    Jamieson C; McCaffrey PG; Rao A; Sen R
    J Immunol; 1991 Jul; 147(2):416-20. PubMed ID: 1830061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa B.
    Berberich I; Shu GL; Clark EA
    J Immunol; 1994 Nov; 153(10):4357-66. PubMed ID: 7525701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased proliferation, cytotoxicity, and gene expression after stimulation of human peripheral blood T lymphocytes through a surface ganglioside (GD3).
    Norihisa Y; McVicar DW; Ghosh P; Houghton AN; Longo DL; Creekmore SP; Blake T; Ortaldo JR; Young HA
    J Immunol; 1994 Jan; 152(2):485-95. PubMed ID: 8283032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of T lymphocyte activation and IL-2 receptor expression by endogenously secreted lymphokines.
    Pimentel-Muiños FX; Muñoz-Fernández MA; Fresno M
    J Immunol; 1994 Jun; 152(12):5714-22. PubMed ID: 8207202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. V7 (CD101) ligation inhibits TCR/CD3-induced IL-2 production by blocking Ca2+ flux and nuclear factor of activated T cell nuclear translocation.
    Soares LR; Tsavaler L; Rivas A; Engleman EG
    J Immunol; 1998 Jul; 161(1):209-17. PubMed ID: 9647226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal NF-kappa B activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression.
    Wong HK; Kammer GM; Dennis G; Tsokos GC
    J Immunol; 1999 Aug; 163(3):1682-9. PubMed ID: 10415075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Hsp90-specific inhibitor geldanamycin selectively disrupts kinase-mediated signaling events of T-lymphocyte activation.
    Schnaider T; Somogyi J; Csermely P; Szamel M
    Cell Stress Chaperones; 2000 Jan; 5(1):52-61. PubMed ID: 10701840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.